• Profile

Researchers outline AI blueprint to help tackle antimicrobial resistance on a global scale

MedicalXpress Breaking News-and-Events Dec 20, 2023

Researchers from the University of Liverpool have outlined a framework for artificial intelligence (AI) to improve antimicrobial use and infection care, helping to address the global challenge of antimicrobial resistance (AMR).

Their blueprint is published in The Lancet Digital Health journal.

Lead author Dr. Alex Howard said, "Different forms of AI bring many opportunities to improve health care. AIs can harness complex evolving data, inform and augment human actions, and learn from outcomes. The global public health challenge of AMR needs large-scale optimization of antimicrobial use and wider infection care, which can be enabled by carefully constructed AIs."

The researchers noted that while AIs become increasingly useful and robust, health care systems remain challenging places for their deployment—and an implementation gap exists between the promise of AIs and their use in patient and population care.

With this in mind, the group has outlined an adaptive implementation and maintenance framework for AIs to improve antimicrobial use and infection care as a learning system. This considers AMR problem identification, law/regulation, organizational support and data processing in relation to AMR-targeted AI development, assessment, maintenance, and scalability.

"Bridging the implementation gap between AI innovation and tackling AMR presents technical, regulatory, organizational, and human challenges. Learning systems built on integrated dataflows, governance, and technologies have the potential to close this gap. Translational expertise between AMR and AI fields will be essential to appropriately design, maintain, normalize, and globalize AMR-AIs in infection care and realize the potential for AIs to support clinician-driven AMR minimization strategies," Dr. Howard said.

The work articulates a vision of how data science can be leveraged to tackle antimicrobial resistance as part of the Centres for Antimicrobial Optimization Network program, a global collaborative bringing together world-leading multidisciplinary expertise in infection and health informatics.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen